StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) shareholders

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.75−0.18 (-0.64%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
94.0%
61M of 65M shares
Institutional holders
145
29 new, 22 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
17 buys · 0 sales
Net bought $11.42M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
FMR LLC
Joint filing with Abigail P. Johnson (14.30%)
7,652,25514.30%13G (passive) amendmentDec 31, 2025
InnoCare Pharma Limited
Joint filing with InnoCare Pharma Inc. (10.40%), Ocean Prominent Limited (10.40%)
7,000,00010.40%13G (passive) amendmentAug 26, 2026
Wellington Investment Advisors Holdings LLP
Joint filing with Wellington Management Group LLP (10.10%), Wellington Group Holdings LLP (10.10%) and 1 more
6,566,13410.10%13G (passive)Aug 31, 2026
Simeon George
Joint filing with SR One Capital Management, LLC (7.70%)
5,037,8547.70%13D (active) amendmentAug 13, 2026
SR One Capital Management, LLC
Joint filing with Simeon George (9.40%)
5,037,8549.40%13D (active) amendmentOct 9, 2025
Ocean Prominent Limited
Joint filing with InnoCare Pharma Inc. (9.40%), InnoCare Pharma Limited (9.40%)
5,000,0009.40%13G (passive)Oct 7, 2025
Enavate Sciences GP, LLC
Joint filing with Zebra Aggregator, LP (7.30%)
3,919,1597.30%13D (active) amendmentOct 9, 2025
Abigail P. Johnson
Joint filing with FMR LLC (7.90%)
3,323,5347.90%13G (passive) amendmentJun 30, 2025
BlackRock, Inc.3,287,0215.00%13G (passive)Sep 30, 2026
Moulder Leon O Jr3,220,8805.09%13D (active)Apr 29, 2026
Rick Yang
Joint filing with NEA 18 Venture Growth Equity, L.P. (6.60%), NEA Partners 18 VGE, L.P. (6.60%) and 8 more
2,613,9486.60%13G (passive)Sep 16, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ZBIOValueChange% of portfolio
FMR LLC9,506,70114.59%$241.28M+424,7010.01%
Sr One Capital Management, LP5,037,8547.73%$127.86M–12.31%
NEA Management Company, LLC4,023,2196.17%$102.11M–6.43%
Enavate Sciences Gp, LLC3,919,1596.01%$99.47M–28.80%
Federated Hermes, Inc.3,116,8054.78%$79.10M−10,2260.11%
BlackRock, Inc.2,686,2254.12%$68.18M+648,6770.00%
Capital International Investors2,502,9123.84%$63.52M+68,9120.01%
Polar Capital Holdings Plc2,412,7723.70%$61.24M−135,6720.14%
Royalty Pharma Sub-Manager, LLC2,388,1503.66%$60.61M–25.05%
Fairmount Funds Management LLC2,359,0253.62%$59.87M–3.96%
State Street Corp2,055,1003.15%$52.16M+584,1770.00%
NVP Associates, LLC1,838,4822.82%$46.66M–14.22%
Wellington Management Group Llp1,593,8192.45%$40.45M+347,7660.01%
Vanguard Capital Management LLC1,354,8642.08%$34.39M+109,4730.00%
Bank Of America Corp /De/1,231,1591.89%$31.25M+842,8120.00%
Price T Rowe Associates Inc /Md/1,226,9281.88%$31.14M+869,6620.00%
Alliancebernstein L.P.1,103,3881.69%$21.57M+206,0670.01%
Geode Capital Management, LLC882,6541.35%$22.41M+226,8690.00%
Two Sigma Investments, LP815,1501.25%$20.69M+540,0940.01%
EcoR1 Capital, LLC789,5001.21%$20.04M–0.97%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202614561M94.0%29 / 6239 / 227M4M
Q1 202614058M88.7%51 / 5817 / 2820M3M
Q4 202511943M65.7%47 / 3724 / 811M3M
Q3 20258035M53.4%14 / 2420 / 72M2M
Q2 20257334M52.3%11 / 3412 / 52M1M
Q1 20256732M49.8%13 / 1421 / 103M2M
Q4 20246532M48.7%35 / 137 / 149M2M
Q3 20244425M38.0%44 / 00 / 025M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

163 funds held ZBIO in Q2 2026, 25% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ZBIOValue% of fundAs of
Vanguard Health Care Fund2,937,0554.51%$92.34M0.24%Jul 31, 2026
SMALLCAP World Fund Inc2,434,0003.73%$61.77M0.07%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1,349,3962.07%$34.25M0.32%Jun 30, 2026
Federated Hermes Kaufmann Fund1,330,0002.04%$41.82M0.85%Jul 31, 2026
Select Health Care Portfolio1,080,0001.66%$19.87M0.34%May 31, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund1,008,1691.55%$18.55M0.01%May 31, 2026
Fidelity Small Cap Growth Fund988,6391.52%$31.08M0.35%Jul 31, 2026
Federated Hermes Kaufmann Small Cap Fund897,0001.38%$28.20M0.99%Jul 31, 2026
Vanguard Total Stock Market Index Fund891,1961.37%$22.62M0.00%Jun 30, 2026
iShares Russell 2000 ETF744,8521.14%$18.90M0.02%Jun 30, 2026
Fidelity Stock Selector Small Cap Fund662,8411.02%$20.84M0.28%Jul 31, 2026
Fidelity Small Cap Growth K6 Fund531,1200.81%$16.70M0.36%Jul 31, 2026
Fidelity Advisor Health Care Fund500,0000.77%$15.72M0.50%Jul 31, 2026
Fidelity Advisor Biotechnology Fund491,7240.75%$15.46M0.70%Jul 31, 2026
AB Small Cap Growth Portfolio467,8480.72%$11.87M0.38%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Leon O. Moulder JrSee Remarks, Director520,0830.80%Jun 17, 2026
Moltke Lisa vonSee Remarks––Jun 17, 2026
Joseph L. FarmerSee Remarks9740.00%Jun 17, 2026
Jennifer A. FoxSee Remarks1,5920.00%Jun 17, 2026
Orlando OliveiraSee Remarks––Jun 12, 2025
Christy J. OligerDirector––Sep 2, 2026
John J. OrloffDirector––Jun 17, 2026
Patrick G. EnrightDirector1,844,6592.83%Jun 17, 2026
Jason Raleigh NunnDirector3,119,9594.79%Jun 17, 2026
Patricia L. AllenDirector19,8600.03%Jun 17, 2026
James P. BoylanDirector––Jun 17, 2026
Hongbo LuDirector426,7360.65%Jun 17, 2026
Funds Management LLC FairmountDirector1,892,8062.90%Apr 1, 2026
Tomas KiselakDirector2,359,0253.62%Apr 1, 2026
Healthcare Fund II L.P. FairmountDirector287,9150.44%Apr 1, 2026
Peter Evan HarwinDirector2,209,0253.39%Apr 1, 2026
Ting XiaoDirector10,0000.02%Apr 28, 2025
Pharma Inc. InnoCare10% owner7,000,00010.74%Sep 8, 2026
Simeon George10% owner––Oct 14, 2025
Sr One Capital Management, Llc10% owner5,037,8547.73%Oct 14, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Leon O. Moulder Jr
Chief Executive Officer, Director
May 18, 2026Buy+60,000$16.88$1.01M96,928
Leon O. Moulder Jr
Chief Executive Officer, Director
Apr 29, 2026Buy+35,000$17.62$616.70K1,786,039
Leon O. Moulder Jr
Chief Executive Officer, Director
Apr 28, 2026Buy+25,000$18.02$450.50K1,751,039
Hongbo Lu
Director
Mar 31, 2026Buy+3,768$18.63$70.20K426,736
Tomas Kiselak
Director
Mar 31, 2026Buy+150,000$20.00$3.00M2,359,025
Hongbo Lu
Director
Mar 31, 2026Buy+75,000$20.00$1.50M422,968
Leon O. Moulder Jr
Chief Executive Officer, Director
Mar 31, 2026Buy+34,000$19.31$656.54K1,726,039
Leon O. Moulder Jr
Chief Executive Officer, Director
Mar 30, 2026Buy+20,000$18.23$364.60K1,692,039
Patricia L. Allen
Director
Feb 13, 2026Buy+4,160$26.36$109.66K19,860
Patricia L. Allen
Director
Feb 12, 2026Buy+5,000$26.50$132.50K15,700
Patricia L. Allen
Director
Feb 12, 2026Buy+5,000$23.77$118.85K5,000
Patricia L. Allen
Director
Feb 12, 2026Buy+5,700$24.34$138.74K10,700
Hongbo Lu
Director
Feb 11, 2026Buy+25,985$22.50$584.66K347,968
Jennifer A. Fox
See Remarks
Feb 5, 2026Award+1,592$13.35$21.25K1,592
Joseph L. Farmer
See Remarks
Feb 5, 2026Award+974$13.35$13.00K974
Leon O. Moulder Jr
Chief Executive Officer, Director
Feb 2, 2026Buy+57,000$17.96$1.02M423,155
Leon O. Moulder Jr
Chief Executive Officer, Director
Jan 9, 2026Buy+20,000$16.55$331.00K366,155
Leon O. Moulder Jr
Chief Executive Officer, Director
Jan 8, 2026Buy+30,000$16.30$489.00K346,155
Leon O. Moulder Jr
Chief Executive Officer, Director
Jan 7, 2026Buy+50,000$16.38$819.00K316,155
Sr One Capital Management, Llc
10% owner
Oct 9, 2025Buy+63,158$19.00$1.20M1,173,395
Sr One Capital Management, Llc
10% owner
Oct 9, 2025Buy+63,157$19.00$1.20M1,917,895
Jason Raleigh Nunn
Director
Oct 9, 2025Buy+63,158$19.00$1.20M1,173,395
Patrick G. Enright
Director
Oct 9, 2025Buy+11,990$20.85$249.99K11,990
Patrick G. Enright
Director
Oct 9, 2025Buy+105,265$19.00$2.00M1,832,669
Leon O. Moulder Jr
See Remarks, Director
Oct 7, 2025Buy+36,928$20.85$769.95K36,928
Peter Evan Harwin
Director
Oct 7, 2025Buy+316,219$19.00$6.01M2,209,025
Hongbo Lu
Director
Oct 7, 2025Buy+263,160$19.00$5.00M321,983
Leon O. Moulder Jr
Chief Executive Officer, Director
Feb 18, 2025Buy+25,000$6.67$166.75K266,155
Ting Xiao
Director
Feb 7, 2025Buy+10,000$7.76$77.60K10,000
Ting Xiao
Director
Feb 7, 2025Buy+10,000$7.76$77.60K47,000
Leon O. Moulder Jr
Chief Executive Officer, Director
Dec 4, 2024Buy+45,000$9.98$449.10K241,155
Leon O. Moulder Jr
Chief Executive Officer, Director
Dec 3, 2024Buy+25,000$10.76$269.00K196,155
Leon O. Moulder Jr
Chief Executive Officer, Director
Nov 19, 2024Buy+2,500$14.57$36.43K171,155
Leon O. Moulder Jr
Chief Executive Officer, Director
Nov 18, 2024Buy+7,500$15.00$112.50K168,655
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 20, 2024Buy+2,367$17.88$42.32K1,669,406
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 20, 2024Buy+2,633$18.97$49.95K1,672,039
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 19, 2024Buy+5,000$17.89$89.45K1,667,039
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 18, 2024Buy+10,000$17.91$179.10K1,662,039
Zebra Aggregator, LP
10% owner
Sep 16, 2024Buy+882,353$17.00$15.00M3,761,359
Zebra Aggregator, LP
10% owner
Sep 16, 2024Conversion+2,879,006––2,879,006
Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington
10% owner
Sep 16, 2024Conversion+200,718––801,624
Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington
10% owner
Sep 16, 2024Conversion+180,635––180,635
Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington
10% owner
Sep 16, 2024Conversion+420,271––600,906
Funds Management LLC Fairmount
Director
Sep 16, 2024Buy+300,000$17.00$5.10M1,892,806
Funds Management LLC Fairmount
Director
Sep 16, 2024Conversion+41,130––329,045
Funds Management LLC Fairmount
Director
Sep 16, 2024Conversion+252,890––581,935
Funds Management LLC Fairmount
Director
Sep 16, 2024Conversion+301,077––1,592,806
Funds Management LLC Fairmount
Director
Sep 16, 2024Conversion+709,794––1,291,729
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 16, 2024Conversion+372,017––1,652,039
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 16, 2024Conversion+164,523––1,280,022
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 16, 2024Conversion+108,381––112,901
Leon O. Moulder Jr
Chief Executive Officer, Director
Sep 16, 2024Conversion+48,254––161,155
Sr One Capital Management, Llc
10% owner
Sep 16, 2024Buy+441,176$17.00$7.50M1,946,564
Sr One Capital Management, Llc
10% owner
Sep 16, 2024Buy+1,352,942$17.00$23.00M1,854,738
Sr One Capital Management, Llc
10% owner
Sep 16, 2024Conversion+1,505,388––1,505,388
Sr One Capital Management, Llc
10% owner
Sep 16, 2024Buy+441,176$17.00$7.50M1,110,237
Sr One Capital Management, Llc
10% owner
Sep 16, 2024Conversion+669,061––669,061
Sr One Capital Management, Llc
10% owner
Sep 16, 2024Conversion+501,796––501,796
Peter Evan Harwin
Director
Sep 16, 2024Conversion+41,130––41,140
Peter Evan Harwin
Director
Sep 16, 2024Conversion+252,890––294,020

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
27.27%
11M shares short
Days to cover
24.1
At 0M shares a day
Change since last report
-9.4%
From 13M shares
Short volume, 20 days
63.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Zenas BioPharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 8,151 shares on Aug 26, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Zebra Aggregator, LP
Affiliate
Aug 19, 20261,000,000$31.91MAug 19, 2026Series B

See a number that looks wrong?